r/pennystocks • u/Avish_Golakiya • 14d ago
ꉓꍏ꓄ꍏ꒒ꌩꌗ꓄ Upcoming catalysts for September 2026 in Biotech and Pharma
•
u/AdFew8591 13d ago
Ran the tickers people named in this thread against Form 4 filings since June. Most have nothing. Two are worth separating, because they look identical in a scanner and are not the same thing at all.
PRQR is the clean one. Five open market buys since 30 June from two insiders, both directors, both starting from zero:
6/30 Filius, 150,000 at $1.54
7/8 de Boer (CEO), 150,000 at $1.59
7/13 de Boer, 150,000 at $1.74
7/21 Filius, 150,000 at $1.7195
8/3 de Boer, 200,000 at $1.7698
de Boer is at 500,000 shares, Filius at 300,000, about $1.34M between them. All code P. They paid up on every purchase instead of averaging down.
OTLK reads the same way in a feed and is not. Four filings dated 8/14, all code P: CEO Jahr 151,515, CFO Kenyon 101,010, Sukhtian 2,525,252. But footnote F1 says those shares were acquired "in the Issuer's underwritten public offering" with accompanying warrants attached, expiring in 2031. That is participating in a financing, not buying from the market. The Sukhtian block is also held through GMS Ventures rather than personally.
OCGN has one code P, the CFO at 21,000 on 6/17 at $1.23. NRXP, KPTI and AUTL have no code P filings in that window at all.
Not telling anyone what to do with that. Just worth knowing the transaction code is identical on PRQR and OTLK, and the footnote is the only thing that separates them.
•
u/Milswanca69 10d ago
Sorry if I’m being a little dense here, you’re suggesting that PRQR and OTLK are the hot ones from the list due to material insider buying (as opposed to stock options/grants), correct?
•
u/AdFew8591 9d ago
Not quite, and that difference is the whole reason I bothered posting it.
$PRQR is the clean one. Two directors, both starting from zero, five purchases between 26 June and 31 July, about $1.34M between them, and they paid a higher price on every successive buy instead of averaging down. No footnotes, nothing structural attached. That is people spending their own money in the market.
$OTLK is the opposite, despite carrying the identical P code. The big August numbers, the 2,525,252 block and the CEO and CFO purchases on the 14th, all carry a footnote saying the shares were acquired in the issuer's own underwritten offering with warrants attached. That is putting money into a raise the company was doing anyway, on terms retail could not get. The 2,525,252 also appears twice, once under GMS Ventures and once under Sukhtian personally, because it is one economic block filed by two related reporters. Count it once.
To be fair to $OTLK, it does have two genuinely clean open-market buys earlier that I did not mention: Haddadin, 29,000 shares at $0.83 on 2 June, and Faisal Sukhtian, 95,398 at $1.05 on 29 July. Around $124k combined. Real, just nowhere near what the August headline number implies.
So one name on that list has insiders buying, and one has insiders funding a financing. Same code in any screener. Only the footnote tells you which is which.
•
•
•
u/Stock-Comment-61 14d ago
Solid list. KPTI and OCGN are the only two I'm watching here, rest look like coin flips. Appreciate you putting it together.
•
•
u/sangy1986 13d ago edited 13d ago
No GOSS on the list.
They will submit the NDA in sept 2026 based on FDA recent meeting.
This the major catalyst as FDA had not asked to rerun phase 3.
Stock down 0.15 range now 0.2 from 3 dollars in feb after the readout.
Similar to TENX and SION (they have bigger cash position but drug was reject after phase 3 also they might get NDA submission after FDA meeting)
•
•
•
u/Avish_Golakiya 14d ago
MRNA, AUTL, OTLK, PRQR, KURA, Alvotech, RARE, VRCA still holding those and now in my watchlist EDIT, AURA, QTTB, AVTX, ALT
please share your watchlist or picks not SLS,🤣 of course I do have small chunk
•
u/WickedFrags 14d ago
Believe it or not, SLS! :))
•
u/Avish_Golakiya 14d ago
I DO believe that’s why I have it and my avg is from last year and enjoying the rally 🚀
•
u/Livid-Grocery7942 13d ago
I respect your opinion and knowledge when it comes to biostocks more than anyone else in the entire internet, no cap. I need to know what you think of HURA
•
•
•
u/MartinoElLoco 12d ago
I'm new at Reddit. How can I enlarge the image? I can't read anything of it 😄
•
u/Emergency_Archer_442 12d ago
so the Form 4 breakdown on PRQR is the kind of thing I wish someone had handed me years ago. learned the hard way that insider buying in a feed looks the same whether it's real conviction or just an offering purchase dressed up nice. the footnote detail on OTLK is exactly what gets people. code P means nothing if you don't read past the first line
•
u/OriginalConference65 11d ago
What’s everyone’s thoughts on FEMY? short interest climbing low shorts available?
•
•
•
•
u/PennyPumper ノ( º _ ºノ) 14d ago
Does this submission fit our subreddit? If it does please upvote this comment. If it does not fit the subreddit please downvote this comment.
I am a bot, and this comment was made automatically. Please contact us via modmail if you have any questions or concerns.